Search for: "The Harvard Drug Group, LLC" Results 21 - 35 of 35
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2012, 6:08 pm by Michael McCann
  TIME: 12:30-1:45pm (Ames Courtroom)PANELISTS: Moderator: Professor Peter Carfagna (Lecturer on Law Harvard Law School, Chairman/CEO Magis LLC) Tim Fleiszer (Representative Sports Legacy Institute, Partner at Gil Sports Management)Mark Moore (Author, Saving the Game)Dr. [read post]
2 Dec 2010, 9:16 am by Roshonda Scipio
. : Lexington Books, c2010.ChinaKNQ500 .L53 2010The draft civil code of the People's Republic of China : English translation / (prepared by the Legislative Research Group of Chinese Academy of Social Sciences) ; by Liang Huixing ; translated from the Chinese by Junwei Fu ... [read post]
19 Jun 2010, 8:03 pm by Brian Y. Silber
The DEA recently suspended the license of Harvard Drug Group, LLC due to questionable oxycodone sales to South Florida pain clinics. [read post]
15 Mar 2010, 2:09 pm by Robinson, Calcagnie & Robinson
Even industry groups and manufacturing executives have acknowledged and reluctantly conceded that litigation has enhanced product safety by changing the way they do business. [read post]
28 Nov 2009, 4:23 pm
Ben Johnson Services, LLC, a business that promotes products for natural health care. [read post]
9 Nov 2009, 6:01 am
Doctors generally don't tell people that they're prescribing drugs pitched to them by pharmaceutical salespeople for unapproved treatments, says Peter Lurie, deputy medical director of Public Citizen, a Washington-based public interest group. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
27 Feb 2009, 5:00 am
(Patent Docs) (Afro-IP) Access to drugs: Gilead’s non exclusive model (Afro-IP) (GenericsWeb) India: Drug patent linkage is subject of court case, dispute in India (Intellectual Property Watch) India: Ranbaxy’s manufacturing woes deepen; USFDA invokes Application Integrity Policy against Paonta Sahib facility (FDA Law Blog) UK patent practice on human embryos post-WARF (IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for… [read post]
11 Jul 2008, 4:30 am
: (IAM), (Patent Circle), India takes open source approach to drug discovery: (Patent Lens), India: Indian Bayh Dole Bill: (Spicy IP), (Spicy IP), (Does India need Bayh-Dole? [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
18 Apr 2008, 2:00 am
: (Spicy IP), India: OPPI recommends timeframe for pre-grant opposition: (Spicy IP), India: Jatropha patents (agri-biotech): (Spicy IP), India & US: Stem cell patents: (Spicy IP), Kenya: GSK presses Kenya to crack down on imports of fake medicines: (Afro-IP), Nigeria: Interview with Director General of NAFDAC - Cracking down on counterfeit drugs: (Afro-IP), EU: No link between parallel trade and reduction in R&D, says AG in Sot. [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
22 Feb 2008, 2:30 am
[www.erikjheels.com]Et Seq.The Harvard Law School Library Blog[etseq.law.harvard.edu]HealthBlawgNew developments in health care law and policy together with the observations and analysis of David Harlow, of The Harlow Group LLC, a health care law and consulting firm in Newton.http://healthblawg.typepad.com/healthblawg/Home Contractor vs. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
6 Nov 2007, 7:43 pm
Torrance, J.D., Ph.D., Professor, University of Kansas School of Law · Lecturer at Harvard University from 1999-2005; · Visiting Professor at Harvard University in 2003; · Chairs the Scientific and Creative Board of the Darwin Project, a major biodiversity institution planned for downtown Boston; · Practiced law at the firm of Fish & Richardson LLC; In-house Counsel at Inverness… [read post]